ELDN · Forms 3, 4, 5
Insider trades at Eledon Pharmaceuticals, Inc.
No open-market insider buys or sells at Eledon Pharmaceuticals, Inc. in the last 90 days; 2 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Eledon Pharmaceuticals, Inc. (ELDN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| David-Alexandre C Gros | Chief Executive Officer | Award | 354,454 | Form 4 | |||
| David-Alexandre C Gros | Chief Executive Officer | Tax withholding | 194,791 | $3.38 | $658K | Form 4 | |
| Steven Perrin | President | Award | 152,353 | Form 4 | |||
| Steven Perrin | President | Tax withholding | 72,138 | $3.38 | $244K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.